Attached files
| file | filename |
|---|---|
| S-1/A - AMENDMENT NO. 2 TO FORM S-1 - ZS Pharma, Inc. | d698362ds1a.htm |
| EX-5.1 - EX-5.1 - ZS Pharma, Inc. | d698362dex51.htm |
| EX-99.2 - EX-99.2 - ZS Pharma, Inc. | d698362dex992.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the reference to our firm under the caption “Experts” and to the use of our report dated April 4, 2014 (except for the last paragraph of Note 1, as to which the date is June X, 2014), in Amendment No. 2 to the Registration Statement (Form S-1 No. 333-195961) and related Prospectus of ZS Pharma, Inc. (a development stage enterprise) for the registration of its common stock.
Dallas, Texas
The foregoing consent is in the form that will be signed upon the effectiveness of the reverse stock split as described in the last paragraph of Note 1 to the financial statements.
/s/ Ernst & Young LLP
Dallas, Texas
June 6, 2014